Clinical Trial Update: Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing Z7200 and Symbicort Turbohaler on respiratory imaging parameters in asthmatic patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)
• Z7200

Snippet

Sponsor: Zambon SpA | Conditions: Asthma, Asthma Chronic | Phase 2 | Status: COMPLETED | Results posted: 2022-01-27